The tumor suppressor p53 is the most commonly mutated gene in BrCa, and functional disruption of p53 is associated with increased tumor aggressiveness, refractoriness to treatment and poorer prognosis [6, 7]. This evidence concerns the gene TP53 and invasive breast carcinoma.